ArticleClinical lymphoma, myeloma & leukemia2024

An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma.

Ibrahim Alodhaibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.